Updated Jul 16, 2026
McHugh Julie has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $80K.

Julie Mchugh is an American corporate director who, as of May 18, 2026, serves on the board of Lantheus Holdings, Inc., a publicly traded medical imaging company. The SEC filing indicates her role as Director on the Lantheus board. The available context does not provide further details on her education or prior positions. Her role entails governance oversight and participation in board-level decisions affecting the company's strategy, governance, and oversight of management.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | IRWD | IRONWOOD PHARMACEUTICALS INC | S — Open-market sale | 21.6K | $3.73 | $80K |
| 2026-06-17 | IRWD | IRONWOOD PHARMACEUTICALS INC | A — Grant or award | 63.5K | $0.00 | |
| 2026-05-18 | LNTH | Lantheus Holdings, Inc. | A — Grant or award | 4.1K | $0.00 |
Julie Mchugh is an American corporate director who, as of May 18, 2026, serves on the board of Lantheus Holdings, Inc., a publicly traded medical imaging company. The SEC filing indicates her role as Director on the Lantheus board. The available context does not provide further details on her education or prior positions. Her role entails governance oversight and participation …
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($80K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live McHugh Julie profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.